Login
Register
Back to News
X4 Pharmaceuticals shares are trading higher after Guggenheim initiated coverage on the stock with a Buy rating and announced a $12 price target.
Benzinga Newsdesk
www.benzinga.com
Positive 94.9%
Neg 0%
Neu 0%
Pos 94.9%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment